Carney complex is a rare multisystem genetic disorder characterized by the development of spotty skin pigmentation, non-cancerous tumors called myxomas, and multiple endocrine and non-endocrine tumors. The endocrine system refers to the body’s hormone-producing glands, and Carney complex is associated with the development of tumors on these glands that can affect hormone production. The condition often presents in childhood or early adulthood with the discovery of small bumps in the skin or discolored brown/black/blue moles (lentigines) around the lips, eyes, or genitalia. Carney complex requires lifelong surveillance due to the risk of recurrent tumors, often reappearing after removal. While most tumor development is benign, development in and around certain organs can pose health issues and complications. Those with Carney complex may develop cardiac myxomas, or tumors growing in one or more chambers of the heart that can disrupt the flow of blood. Additionally, about 25% of people with Carney complex develop a specific type of tumor of the adrenal glands called primary pigmented nodular adrenocortical disease (PPNAD), which can affect cortisol levels and lead to health issues. About 10% of individuals with Carney complex develop a very rare tumor type in cells that protect nerve cells called psammomatous melanotic schwannoma (PMS). While Carney complex is not inherently dangerous, the risk of developing tumors that inhibit important processes is greater in these individuals and requires monitoring.
Carney complex is a rare multisystem genetic disorder characterized by the development of spotty skin pigmentation, non-cancerous tumors called myxomas, and multiple endocrine and non-endocrine tumors. The endocrine system refers to the body’s hormone-producing glands, and Carney complex is associated with the development of tumors on these glands that can affect hormone production. The condition often presents in childhood or early adulthood with the discovery of small bumps in the skin or discolored brown/black/blue moles (lentigines) around the lips, eyes, or genitalia. Carney complex requires lifelong surveillance due to the risk of recurrent tumors, often reappearing after removal. While most tumor development is benign, development in and around certain organs can pose health issues and complications. Those with Carney complex may develop cardiac myxomas, or tumors growing in one or more chambers of the heart that can disrupt the flow of blood. Additionally, about 25% of people with Carney complex develop a specific type of tumor of the adrenal glands called primary pigmented nodular adrenocortical disease (PPNAD), which can affect cortisol levels and lead to health issues. About 10% of individuals with Carney complex develop a very rare tumor type in cells that protect nerve cells called psammomatous melanotic schwannoma (PMS). While Carney complex is not inherently dangerous, the risk of developing tumors that inhibit important processes is greater in these individuals and requires monitoring.
Carney complex is extremely rare, with an estimated prevalence of fewer than 1 in 1,000,000 individuals worldwide. About 750 cases total have been reported, often during early childhood with the appearance of sporadic bumps. Both males and females are affected equally. Many cases are familial, though sporadic cases also occur. Because of variable expression, the disorder may be underdiagnosed.
| Name | Abbreviation |
|---|---|
| Carney syndrome | |
| Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity | |
| Lentigines, atrial myxoma, mucocutaneous myoma, blue nevi | LAMB |
| Nevi, atrial myxoma, skin myxoma, ephelides | NAME |
Carney complex is most commonly caused by mutations in the PRKAR1A gene, which encodes the regulatory subunit type 1-alpha of protein kinase A (PKA). This protein plays a critical role in regulating cell growth and hormone signaling. Loss-of-function mutations in PKA lead to uncontrolled cellular growth and production of hormones, leading to tumor development and a dysregulated endocrine system. The condition is inherited in an autosomal dominant manner in about 70% of cases, though approximately 30% of cases result from spontaneous mutations in offspring (see Rareshare Guide on Genetic Inheritance). Rarely, other genetic loci may be involved. A region on the short (p) arm of chromosome 2 called 2p16 has been associated with an increased risk of Carney complex (see Rareshare Guide on Chromosomal Nomenclature), yet research is ongoing.
Symptoms vary widely depending on the organs involved and may include:
Skin findings: Lentigines (small brown-to-black spots) on the face, lips, eyelids, genitalia; blue nevi which are raised moles with a bluish color
Cardiac myxomas: tumors in one or more chambers of the heart that can cause shortness of breath, syncope, embolic stroke, or sudden death
Endocrine tumors and overactivity:
Primary pigmented nodular adrenocortical disease (PPNAD) → Cushing syndrome, an overproduction of cortisol hormone that can lead to weight gain, slow growth in children, bone loss, and fragile skin
Pituitary adenomas → Excess growth hormone (acromegaly), causing enlarged hands and feet, arthritis, and distinct facial features
Testicular tumors (large-cell calcifying Sertoli cell tumors) → Gynecomastia or infertility
Thyroid nodules or cancer
Other tumors: Cutaneous, breast, nerve sheath (psammomatous melanotic schwannomas which are tumors that form in the Schwann cell type that protects nerves), and bone lesions
Symptoms may appear gradually and recur throughout life.
Diagnosis is based on clinical criteria, family history, and genetic testing. A diagnosis can be made when two or more characteristic features are present, or when one feature is present in a patient with a confirmed PRKAR1A mutation or a first-degree relative with Carney complex.
Genetic testing: Identification of a pathogenic PRKAR1A mutation
Echocardiography: Regular screening for cardiac myxomas
Hormonal testing: Cortisol, growth hormone, prolactin, thyroid hormones, and sex hormones
Imaging studies:
MRI or CT of adrenal glands, pituitary, thyroid, and testes/ovaries
Ultrasound for thyroid and testicular lesions
Skin examination and biopsy: For pigmented lesions or myxomas
Periodic surveillance testing: Essential due to high recurrence risk
Treatment is individualized and focuses on tumor removal, hormonal control, and long-term surveillance:
Surgical excision of cardiac myxomas and other symptomatic or malignant tumors
Endocrine management:
Adrenalectomy for PPNAD - removal of part or all of the adrenal gland located above the kidney
Medical or surgical treatment of pituitary adenomas
Hormone-suppressive therapies when appropriate
Lifelong monitoring with regular cardiac, endocrine, and imaging evaluations
Genetic counseling for affected individuals and family members
With early diagnosis and careful monitoring, individuals with Carney complex can have a near-normal life expectancy. However, prognosis depends on timely detection and treatment of the possible cardiac myxomas and endocrine tumors, which can be life-threatening if untreated. Tumor recurrence is common, necessitating lifelong follow-up. Advances in genetic testing, imaging, and surgical techniques have significantly improved outcomes and quality of life for affected individuals.
Hello there, Have got diagnosed with Carney Complex about a month ago following by a cardiac myxoma which was removed about 15 years ago and recent benign testicular tumor which has been removed also. I learn that this complex makes the body to produce tumors virtually anywhere in the body including thyroid gland and brain. Very worrying!!! I can see there are a few members of this comunity, who might want to share their experience. Please, spread the info. Knowlesge is the Power!
i looked every where to see if they had already started a community but there wasnt.we just started test at drs. office.so i will update with more information.my daughter is nine and very much an angel.if every one could live there lifes through a childs eyes.sometimes i think she should be the mom.
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Created by zoomyman | Last updated 25 Jan 2014, 06:11 PM
Created by dafad123 | Last updated 21 Feb 2011, 11:41 AM
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITY
Our rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.